Annals ofRheumatology

Volume: 2 - Number: 17 - November 15, 2002

Outstanding

Bacterial induction of autoantibodies to ß2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome

Antiphospholipid-Protein Antibodies and Ischemic Stroke : Not Just Cardiolipin Anymore

Seasonal Distribution of Antiphospholipid Antibodies

Antiphospholipid Antibodies From Antiphospholipid Syndrome Patients Activate Endothelial Cells In Vitro and In Vivo

Antiphospholipids Syndrome

Superficial Thrombophlebitis

Cerebral Sinovenous Thrombosis in Children

Advances in Immunology: Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune Globulin

Medical Progress: The Antiphospholipid Syndrome

The clonal analysis of anticardiolipin antibodies in a single patient with primary antiphospholipid syndrome reveals an extreme antibody heterogeneity

Bacterial induction of autoantibodies to ß2-glycoprotein-I accounts for the infectious etiology of antiphospholipid syndrome

Autoreactive CD4+ T-cell clones to 2-glycoprotein I in patients with antiphospholipid syndrome: preferential recognition of the major phospholipid-binding site

Restricted T-cell receptor -chain usage by T cells autoreactive to 2-glycoprotein I in patients with antiphospholipid syndrome

Heart Valve Involvement (Libman-Sacks Endocarditis) in the Antiphospholipid Syndrome

Antiphospholipid antibodies and antiphospholipid syndrome in patients presenting with immune thrombocytopenic purpura: a prospective cohort study

Thrombogenic Properties of Murine Anti-Cardiolipin Antibodies Induced by ß2 Glycoprotein 1 and Human Immunoglobulin G Antiphospholipid Antibodies

Hydroxychloroquine Reverses Thrombogenic Properties of Antiphospholipid Antibodies in Mice

Hypercoagulable State in Patients With Antiphospholipid Syndrome Is Related to High Induced Tissue Factor Expression on Monocytes and to Low Free Protein S

Differential Effects of Anti–ß2-Glycoprotein I Antibodies on Endothelial Cells and on the Manifestations of Experimental Antiphospholipid Syndrome

Antiphospholipid-Protein Antibodies and Ischemic Stroke : Not Just Cardiolipin Anymore

Antiphospholipid Syndrome in the Elderly: Caution

Neurometabolite Markers of Cerebral Injury in the Antiphospholipid Antibody Syndrome of Systemic Lupus Erythematosus

Thrombogenic Effects of Antiphospholipid Antibodies Are Mediated by Intercellular Cell Adhesion Molecule-1, Vascular Cell Adhesion Molecule-1, and P-Selectin

Anticardiolipin Antibodies From Patients With the Antiphospholipid Antibody Syndrome Recognize Epitopes in Both ß2-Glycoprotein 1 and Oxidized Low-Density Lipoprotein

2001: A Prospective, Seasonal Odyssey Into Antiphospholipid Protein Antibodies

Seasonal Distribution of Antiphospholipid Antibodies

Molecular Pathogenesis of the Antiphospholipid Syndrome

Antiphospholipid Antibodies From Antiphospholipid Syndrome Patients Activate Endothelial Cells In Vitro and In Vivo

Autoantibodies

Mutations in Coagulation Factors in Women with Unexplained Late Fetal Loss

Autoimmunes Diseses

Autoantibodies to alfha-IIb-beta3 in patients with chronic immune thrombocytopenic purpura bind primarily to epitopes on alfha-II-b

Autoimmunity

A gene therapy approach for treating T-cell-mediated autoimmune diseases

Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated, pure red cell aplasia and hemolytic anemia

Original Papers

Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression

Exposure of Mice to Topical Bovine Thrombin Induces Systemic Autoimmuniity

Cardiac Myosin and the TH1/TH2 Paradigm in Autoimmune Myocarditis

Thyroid-stimulating autoantibodies in Graves disease preferentially recognize the free A subunit, not the thyrotropin holoreceptor